Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...
GlobalData on MSN4d
Moderna reports decline in Q4 2024 revenue
Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024 - a sharp decline from the $2.8bn recorded in the ...
Benzinga.com28d
Moderna Secures European Contract For Covid-19 Vaccine
granted marketing authorization for an updated formulation of Moderna’s COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1, for individuals six months and older. See Also ...
Moderna Swings to 4Q Loss After Early Launch of Updated Vaccine
Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter.
STAT7d
U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...
Business Insider29d
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
1, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older. About Moderna Moderna is a leader in the creation of the field of mRNA medicine.